Publications by authors named "Coby Carlson"

Claim this Profile
C
Comparative study for the IMI2-NeuroDeRisk project on microelectrode arrays to derisk drug-induced seizure liability.
Jin Zhai, Martin Traebert, Kurt Zimmermann, Annie Delaunois, Leandro Royer, Coby Carlson

J Pharmacol Toxicol Methods· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Assays for Characterizing Compound Effects on Induced Pluripotent Stem Cell-Derived Cardiac Spheroids.
Oksana Sirenko, Michael K Hancock, Carole Crittenden, Matthew Hammer, Sean Keating, Coby B Carlson

Assay Drug Dev Technol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular Phenotyping Combines Molecular Information, Biological Relevance, and Patient Data to Improve Productivity of Early Drug Discovery.
Faye Marie Drawnel, Jitao David Zhang, Erich Küng, Natsuyo Aoyama, Fethallah Benmansour, Coby Carlson

Cell Chem Biol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Drug-Drug Interactions In Vitro: A Case Study Evaluating the Effects of Sofosbuvir and Amiodarone on hiPSC-Derived Cardiomyocytes.
Daniel C Millard, Christopher J Strock, Coby B Carlson, Natsuyo Aoyama, Krisztina Juhasz

Toxicol Sci· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic Characterization of Toxic Compound Effects on Liver Spheroids Derived from iPSC Using Confocal Imaging and Three-Dimensional Image Analysis.
Oksana Sirenko, Michael K Hancock, Jayne Hesley, Dihui Hong, Avrum Cohen, Coby B Carlson

Assay Drug Dev Technol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A bioluminescent assay for measuring glucose uptake.
Michael P Valley, Natasha Karassina, Natsuyo Aoyama, Coby Carlson, James J Cali

Anal Biochem· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells.
Faye M Drawnel, Stefano Boccardo, Michael Prummer, Frédéric Delobel, Alexandra Graff, Coby Carlson

Cell Rep· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic screening with human iPS cell-derived cardiomyocytes: HTS-compatible assays for interrogating cardiac hypertrophy.
Coby Carlson, Chad Koonce, Natsuyo Aoyama, Shannon Einhorn, Steve Fiene

J Biomol Screen· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leucine-rich repeat kinase 2 functionally interacts with microtubules and kinase-dependently modulates cell migration.
Mareike Caesar, Susanne Zach, Coby B Carlson, Kathrin Brockmann, Thomas Gasser

Neurobiol Dis· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for novel LRRK2 inhibitors using a high-throughput TR-FRET cellular assay for LRRK2 Ser935 phosphorylation.
Spencer B Hermanson, Coby B Carlson, Steven M Riddle, Jing Zhao, Kurt W Vogel

PLoS One· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological inhibition of LRRK2 cellular phosphorylation sites provides insight into LRRK2 biology.
Jing Zhao, Spencer B Hermanson, Coby B Carlson, Steven M Riddle, Kurt W Vogel

Biochem Soc Trans· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterization of an isoform-selective inhibitor of PI3K-p110β as a potential anticancer agent.
Jing Ni, Qingsong Liu, Shaozhen Xie, Coby Carlson, Thanh Von

Cancer Discov· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.
Surya K De, Elisa Barile, Vida Chen, John L Stebbins, Jason F Cellitti, Coby B Carlson

Bioorg Med Chem· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurement of the cellular deacetylase activity of SIRT1 on p53 via LanthaScreen® technology.
Matthew B Robers, Christine Loh, Coby B Carlson, Hongying Yang, Elizabeth A Frey

Mol Biosyst· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis, and structure-activity relationships of 3-ethynyl-1H-indazoles as inhibitors of the phosphatidylinositol 3-kinase signaling pathway.
Elisa Barile, Surya K De, Coby B Carlson, Vida Chen, Christine Knutzen

J Med Chem· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BacMam-enabled LanthaScreen cellular assays for PI3K/Akt pathway compound profiling in disease-relevant cell backgrounds.
Coby B Carlson, Michael J Mashock, Kun Bi

J Biomol Screen· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A toolbox approach to high-throughput TR-FRET-based SUMOylation and DeSUMOylation assays.
Coby B Carlson, Robert A Horton, Kurt W Vogel

Assay Drug Dev Technol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of LanthaScreen cellular assays for key components within the PI3K/AKT/mTOR pathway.
Coby B Carlson, Matthew B Robers, Kurt W Vogel, Thomas Machleidt

J Biomol Screen· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular LanthaScreen and beta-lactamase reporter assays for high-throughput screening of JAK2 inhibitors.
Matthew B Robers, Thomas Machleidt, Coby B Carlson, Kun Bi

Assay Drug Dev Technol· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective tumor cell targeting using low-affinity, multivalent interactions.
Coby B Carlson, Patricia Mowery, Robert M Owen, Emily C Dykhuizen, Laura L Kiessling

ACS Chem Biol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bifunctional ligands that target cells displaying the alpha v beta3 integrin.
Robert M Owen, Coby B Carlson, Jinwang Xu, Patricia Mowery, Elisabetta Fasella

Chembiochem· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory properties of nucleic acid-binding ligands on protein synthesis.
Abba Malina, Shakila Khan, Coby B Carlson, Yuri Svitkin, Isabelle Harvey

FEBS Lett· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition of double-stranded RNA by proteins and small molecules.
Coby B Carlson, Olen M Stephens, Peter A Beal

Biopolymers· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preferred RNA binding sites for a threading intercalator revealed by in vitro evolution.
Coby B Carlson, Momchilo Vuyisich, Barry D Gooch, Peter A Beal

Chem Biol· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selection of small-molecule mediators of the RNA regulation of PKR, the RNA-dependent protein kinase.
Coby B Carlson, Richard J Spanggord, Peter A Beal

Chembiochem· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis